Sale and transfer of assets of pharmaceutical company which researches, develops, manufactures, and markets a dietary supplement product to treat allergic diseases such as allergic rhinitis, also known as hay fever, and atopic asthma, including the 'Immun-Eeze' patent, know-how, technology, trade names, trademark and processes.